Intrathecal amikacin administration. Use in the treatment of gentamicin-resistant Klebsiella pneumoniae meningitis.
D000328:Adult; D000583:Amikacin / Q000008:administration & dosage* / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D006259:Craniocerebral Trauma / Q000150:complications; D004352:Drug Resistance, Microbial; D005839:Gentamicins / Q000494:pharmacology*; D006801:Humans; D007278:Injections, Spinal; D007612:Kanamycin / Q000031:analogs & derivatives*; D007710:Klebsiella Infections / Q000188:drug therapy*; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000302:isolation & purification; D008297:Male; D008581:Meningitis / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology
D005839:Gentamicins; D007612:Kanamycin; D000583:Amikacin